U.S. Delegation

"Life Sciences Exchange Project" Conference

Center of Magnetic Resonance (CERM) - Università degli Studi di Firenze, May 12, 2006

Fluorous Technologies, Inc

Philip E. Yeske, Ph.D.
President & CEO

Fluorous Technologies, Inc. (FTI) was founded by Professor Dennis P. Curran in June 2000 with seed capital from Albany Molecular Research, Inc. and Dr. Alfred Bader, and with intellectual property (IP) from the University of Pittsburgh.

Fluorous Technologies, Inc. (FTI) is a chemical technology company dedicated to the development and commercialization of fluorous products focused at the life science market. The company uses patented technology to solve synthesis and separation problems spanning the entire drug discovery and development process. FTI further leverages its enabling technology through service contracts, licenses, and collaborations. Our main business activities include:

• Sales of fluorous products and separation media
• Custom design and synthesis of new fluorous products and fluorous sorbents
• Custom design and manufacture of small-molecule combinatorial libraries
• Process research and development for fluorous chemical processes
• Consulting, IP licensing and customer support

Our products are novel chemical and sorbent tools that facilitate the synthesis and separation of drug candidates. Our contract research services focus on projects ranging from early-stage library generation to late-stage manufacturing process development for pharmaceutical and biotechnology companies.